PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that the Company is presenting at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society being held on October 12-15, 2014 in San Diego. Scheduled conference presentations include the following:
October 12, 2014 – A poster presentation titled, “Kinetics of DPC-mediated delivery of cholesterol-conjugated RNAi triggers and their subcellular processing in vivo,” will be presented by Christine Woodell, Ph.D., Group Leader
October 15, 2014 – An oral presentation titled, “Development of RNAi-based therapeutics using Dynamic Polyconjugate (DPC) delivery technology,” will be presented by David Lewis, Ph.D., Chief Scientific Officer
Help employers find you! Check out all the jobs and post your resume.
